Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Abstract

Inflammation has been established as an important determinant of cardiovascular disease progression. Currently, clinical examination, laboratory and imaging tests are invaluable for the diagnosis, prognosis and disease monitoring. Novel inflammatory biomarkers are also used to better restratify patients in risk groups but their potential to guide treatment decisions and management of patients has not been extensively evaluated. Therefore, in this review article we present the most recent data concerning the use of inflammatory biomarkers in cardiovascular therapeutics.

Keywords: Atherosclerosis, biomarkers, cardiovascular diseases, coronary artery disease, heart failure, hypertension, inflammation, peripheral artery disease, stroke.


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy